Tolerance to melanin-associated antigen in autoimmune uveitis is mediated by CD4+CD25+ T-regulatory cells

American Journal of Pathology

Volumn 173, Issue 5, 2008, Pages 1440-1454

  Matta, Bharati ^a   Jha, Purushottam ^a   Bora, Puran S ^a   Bora, Nalini S ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MELANIN ASSOCIATED ANTIGEN; RECOMBINANT INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DONOR; DRUG DOSE COMPARISON; DRUG DOSE SEQUENCE; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; IRIDOCYCLITIS; LEWIS RAT; LYMPH NODE CELL; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECIPIENT; SINGLE DRUG DOSE;

EID: 55349098514     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080150     Document Type: Article

References (60)

1. Gritz DC, Wong IG: Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 2004, 111:491-500
2. Bora NS, Kaplan HJ: Intraocular diseases - anterior uveitis. Chem Immunol Allergy 2007, 92:213-220
3. Bloch-Michel E, Nussenblatt RB: International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987, 103:234-235
4. von Herrath MG, Harrison LC: Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003, 3:223-232
5. Broekhuyse RM, Kuhlman ED, Winkens HJ, Van Vugt AHM: Experimental autoimmune anterior uveitis (EAAU), a new form of experimental uveitis: I: induction by a detergent-insoluble, intrinsic protein fraction of the retina pigment epithelium. Exp Eye Res 1991, 52:465-474
6. Bora NS, Kim MC, Kabeer NH, Simpson SC, Tandhasetti MT, Cirrito TP, Kaplan AD, Kaplan HJ: Experimental autoimmune anterior uveitis. Induction with melanin-associated antigen from the iris and ciliary body. Invest Ophthalmol Vis Sci 1995, 36:1056-1066
7. Kim MC, Kabeer NH, Tandhasetti MT, Kaplan HJ, Bora NS: Immunohistochemical studies in melanin associated antigen (MAA) induced experimental autoimmune anterior uveitis (EAAU). Curr Eye Res 1995, 14:703-710
8. Bora NS, Woon MD, Tandhasetti MT, Cirrito TP, Kaplan HJ: Induction of experimental autoimmune anterior uveitis by a self-antigen: melanin complex without adjuvant. Invest Ophthalmol Vis Sci 1997, 38:2171-2175
9. Woon MD, Kaplan HJ, Bora NS: Kinetics of cytokine production in experimental autoimmune anterior uveitis (EAAU). Curr Eye Res 1998, 17:955-961
10. Jha P, Sohn JH, Xu Q, Nishihori H, Wang Y, Nishihori S, Manickam B, Kaplan HJ, Bora PS, Bora NS: The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 2006, 47:1030-1038
11. Bora NS, Sohn JH, Kang SG, Cruz JM, Nishihori H, Suk HJ, Wang Y, Kaplan HJ, Bora PS: Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J Immunol 2004, 172:7086-7094
12. Kamradt T, Mitchison NA: Tolerance and autoimmunity. N Engl J Med 2001, 344:655-664
13. Miller SD, Turley DM, Podojil JR: Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol 2007, 7:665-677
14. Gregerson DS, Obritsch WF, Donoso LA: Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 1993, 151:5751-5761
15. Faria AM, Weiner HL: Oral tolerance. Immunol Rev 2005, 206:232-259
16. Weiner HL, Friedman A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA: Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994, 12:809-837
17. Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N: Treatment of autoimmune disease by oral tolerance to autoantigens. Clin Immunol Immunopathol 1996, 80(Suppl 3):S31-S39
18. Bai XF, Link H: Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine. Clin Exp Allergy 2000, 30:1688-1696
19. Vrabec TR, Gregerson DS, Dua HS, Donoso LA: Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides. Autoimmunity 1992, 12:175-184
20. + T cells. J Immunol 1999, 163:2592-2600
21. Liu JQ, Bai XF, Shi FD, Xiao BG, Li HL, Levi M, Mustafa M, Wahren B, Link H: Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99. Int Immunol 1998, 10:1139-1148
22. Verbeek R, van der Mark K, Wawrousek EF, Plomp AC, van Noort JM: Tolerization of an established alphaB-crystallin-reactive T-cell response by intravenous antigen. Immunology 2007, 121:416-426
23. Gregorian SK, Clark L, Heber-Katz E, Amento EP, Rostami A: Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis. Cell Immunol 1993, 150:298-310
24. Jacobs MJ, van den Hoek AE, van de Putte LB, van den Berg WB: Anergy of antigen-specific T lymphocytes is a potent mechanism of intravenously induced tolerance. Immunology 1994, 82:294-300
25. Sun JB, Czerkinsky C, Holmgren J: Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells. Scand J Immunol 2007, 66:278-286
26. Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA: Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology 2006, 117:433-442
27. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G: Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J Exp Med 2002, 196:247-253
28. Hilliard BA, Kamoun M, Ventura E, Rostami A: Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells. Exp Mol Pathol 2000, 68:29-37
29. Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998, 188:287-296
30. Jha P, Sohn JH, Xu Q, Wang Y, Kaplan HJ, Bora PS, Bora NS: Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J Immunol 2006, 176:7221-7231
31. Thorstenson KM, Khoruts A: Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001, 167:188-195
32. Riemekasten G, Langnickel D, Enghard P, Undeutsch R, Humrich J, Ebling FM, Hocher B, Humaljoki T, Neumayer H, Burmester GR, Hahn BH, Radbruch A, Hiepe F: Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells. J Immunol 2004, 173:5835-5842
33. Warren KG, Catz I, Ferenczi LZ, Krantz MJ: Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment. Eur J Neurol 2006, 13:887-895
34. Sakaguchi S: Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562
35. Kao JK, Hsue YT, Lin CY: Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients. J Microbiol Immunol Infect 2007, 40:419-427
36. McGeachy MJ, Stephens LA, Anderton SM: Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 2005, 175:3025-3032
37. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of selftolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164
38. + regulatory T cells. Arch Immunol Ther Exp (Warsz) 2006, 54:307-321
39. Morris GP, Kong YC: Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. J Autoimmun 2006, 26:24-31
40. Zwar TD, Read S, van Driel IR, Gleeson PA: CD46+CD25+ regulatory T cells inhibit the antigen-dependent expansion of self-reactive T cells in vivo. J Immunol 2006, 176:1609-1617
41. Valencia X, Yarboro C, Illei G, Lipsky PE: Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178:2579-2588
42. Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D, Ma Y: Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006, 176:4484-4491
43. Kelchtermans H, De Klerck B, Mitera T, Van Balen M, Bullens D, Billiau A, Leclercq G, Matthys P: Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res Ther 2005, 7:R402-R415
44. van Puijvelde GH, van Es T, van Wanrooij EJ, Habets KL, de Vos P, van der Zee R, van Eden W, van Berkel TJ, Kuiper J: Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:2677-2683
45. Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, Kuchroo VK, Weiner HL: IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 2004, 16:249-256
46. Li MO, Sanjabi S, Flavell RA: Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006, 25:455-471
47. Prakken BJ, Roord S, van Kooten PJ, Wagenaar JP, van Eden W, Albani S, Wauben MH: Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Arthritis Rheum 2002, 46:1937-1946
48. Khoury SJ, Hancock WW, Weiner HL: Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992, 176:1355-1364
49. Brand DD, Myers LK, Whittington KB, Latham KA, Stuart JM, Kang AH, Rosloniec EF: Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model. J Immunol 2006, 168:490-498
50. Treschow AP, Bäcklund J, Holmdahl R, Issazadeh-Navikas S: Intrinsic tolerance in autologous collagen-induced arthritis is generated by CD152-dependent CD4+ suppressor cells. J Immunol 2005, 174:6742-6750
51. Kresina TF, Moskowitz RW: Adoptive transfer of suppression of arthritis in the mouse model of collagen-induced arthritis. Evidence for a type II collagen-specific suppressor T cell. J Clin Invest 1985, 75:1990-1998
52. Londei M: Role of regulatory T cells in experimental arthritis and implications for clinical use. Arthritis Res Ther 2005, 7:118-120
53. Antony PA, Paulos CM, Ahmadzadeh M, Akpinarli A, Palmer DC, Sato N, Kaiser A, Hinrichs CS, Klebanoff CA, Tagaya Y, Restifo NP: Interleukin-2- dependent mechanisms of tolerance and immunity in vivo. J Immunol 2006, 176:5255-5266
54. Malek TR, Bayer AL: Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004, 4:665-674
55. Sojka DK, Bruniquel D, Schwartz RH, Singh NJ: IL-2 secretion by CD4+ T cells in vivo is rapid, transient, and influenced by TCR-specific competition. J Immunol 2004, 172:6136-6143
56. de la Rosa M, Rutz S, Dorninger H, Scheffold A: Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 2004, 34:2480-2488
57. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S: Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998, 10:1969-1980
58. Maloy KJ, Powrie F: Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat Immunol 2005, 6:1071-1072
59. Hwang KW, Sweatt WB, Mashayekhi M, Palucki DA, Sattar H, Chuang E, Alegre ML: Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice. J Immunol 2004, 173:5415-5424
60. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C: Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998, 10:371-378